Abstract
A major clinical problem encountered with the use of non-steroidal anti-inflammatory drugs (NSAIDs), is gastrointestinal complications. We previously reported that NSAIDs induce both necrosis and apoptosis in vitro. We here examined the cyclooxygenase (COX) dependency of this cytotoxic effect of NSAIDs and its involvement in NSAID-induced gastric lesions. Necrosis and apoptosis by NSAIDs was observed with all selective COX-2 inhibitors except rofecoxib and was not inhibited by exogenously added prostaglandin E 2, suggesting that cytotoxicity of NSAIDs seems to be independent of the inhibition of COX. Intravenously administered indomethacin, which completely inhibited COX activity at gastric mucosa, did not produce gastric lesions. Orally administered selective COX-2 inhibitors, which did not inhibit COX at gastric mucosa, also did not produce gastric lesions. Interestingly, a combination of the oral administration of each of all selective COX-2 inhibitors except rofecoxib with the intravenous administration of indomethacin clearly produced gastric lesions. These results suggest that in addition to COX inhibition by NSAIDs, direct cytotoxicity of NSAIDs may be involved in NSAID-induced gastric lesions.
Original language | English |
---|---|
Pages (from-to) | 575-585 |
Number of pages | 11 |
Journal | Biochemical Pharmacology |
Volume | 67 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2004 Feb 1 |
Keywords
- Cyclooxygenase
- Direct cytotoxicity
- Gastric lesions
- NSAIDs
- Prostaglandin E
- Selective cyclooxygenase-2 inhibitors
ASJC Scopus subject areas
- Biochemistry
- Pharmacology